HealthCare Global Enterprises Limited

NSE HCG.NS

HealthCare Global Enterprises Limited EBIT for the year ending March 31, 2024: USD 21.11 M

HealthCare Global Enterprises Limited EBIT is USD 21.11 M for the year ending March 31, 2024, a 21.87% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • HealthCare Global Enterprises Limited EBIT for the year ending March 31, 2023 was USD 17.32 M, a -28.04% change year over year.
  • HealthCare Global Enterprises Limited EBIT for the year ending March 31, 2022 was USD 24.07 M, a 257.71% change year over year.
  • HealthCare Global Enterprises Limited EBIT for the year ending March 31, 2021 was USD -15.26 M, a -643.05% change year over year.
  • HealthCare Global Enterprises Limited EBIT for the year ending March 31, 2020 was USD 2.81 M, a -19.58% change year over year.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
Loading...
NSE: HCG.NS

HealthCare Global Enterprises Limited

CEO Mr. Meghraj Arvindrao Gore
IPO Date March 31, 2016
Location India
Headquarters Unity Building Complex
Employees 6,150
Sector Health Care
Industries
Description

HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2021, it operated 23 cancer centers, including 1 center of excellence in Bengaluru, 2 freestanding diagnostic centers, and 1 day care chemotherapy center across India, as well as 1 cancer center in Africa. The company was founded in 1989 and is based in Bengaluru, India.

Similar companies

NH.NS

Narayana Hrudayalaya Limited

USD 14.93

1.77%

INDOCO.NS

Indoco Remedies Limited

USD 3.76

0.04%

THYROCARE.NS

Thyrocare Technologies Limited

USD 9.54

0.38%

ASTERDM.NS

Aster DM Healthcare Limited

USD 5.77

1.93%

SHALBY.NS

Shalby Limited

USD 2.56

3.36%

StockViz Staff

January 15, 2025

Any question? Send us an email